These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18829269)

  • 1. The dopamine agonist apomorphine differentially affects cognitive performance in alcohol dependent patients and healthy controls.
    Schellekens AF; van Oosterwijck AW; Ellenbroek B; de Jong CA; Buitelaar JK; Cools L; Verkes RJ
    Eur Neuropsychopharmacol; 2009 Jan; 19(1):68-73. PubMed ID: 18829269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychopathological correlates of reduced dopamine receptor sensitivity in depression, schizophrenia, and opiate and alcohol dependence.
    Schmidt K; Nolte-Zenker B; Patzer J; Bauer M; Schmidt LG; Heinz A
    Pharmacopsychiatry; 2001 Mar; 34(2):66-72. PubMed ID: 11302566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced dopamine receptor sensitivity as an intermediate phenotype in alcohol dependence and the role of the COMT Val158Met and DRD2 Taq1A genotypes.
    Schellekens AF; Franke B; Ellenbroek B; Cools A; de Jong CA; Buitelaar JK; Verkes RJ
    Arch Gen Psychiatry; 2012 Apr; 69(4):339-48. PubMed ID: 22474103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of apomorphine on cognitive performance and sensorimotor gating in humans.
    Schellekens AF; Grootens KP; Neef C; Movig KL; Buitelaar JK; Ellenbroek B; Verkes RJ
    Psychopharmacology (Berl); 2010 Jan; 207(4):559-69. PubMed ID: 19834690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: effects of pramipexole and pergolide on working memory.
    Costa A; Peppe A; Dell'Agnello G; Caltagirone C; Carlesimo GA
    Neuropsychologia; 2009 Apr; 47(5):1374-81. PubMed ID: 19428401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of apomorphine on attentional processing in Parkinson's disease.
    Růzicka E; el Massioui F; Pillon B; Dubois B; Renault B; Agid Y
    Sb Lek; 1999; 100(2):85-99. PubMed ID: 11220166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia.
    Dolan RJ; Fletcher P; Frith CD; Friston KJ; Frackowiak RS; Grasby PM
    Nature; 1995 Nov; 378(6553):180-2. PubMed ID: 7477319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Priming of rotational behavior by a dopamine receptor agonist in Hemiparkinsonian rats: movement-dependent induction.
    Simola N; Di Chiara G; Daniels WM; Schallert T; Morelli M
    Neuroscience; 2009 Feb; 158(4):1625-31. PubMed ID: 19063947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of "enriched environment" during development on adult rat behavior and response to the dopamine receptor agonist apomorphine.
    Hoffmann LC; Schütte SR; Koch M; Schwabe K
    Neuroscience; 2009 Feb; 158(4):1589-98. PubMed ID: 19110038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apomorphine effects on episodic memory in young healthy volunteers.
    Montoya A; Lal S; Menear M; Duplessis E; Thavundayil J; Schmitz N; Lepage M
    Neuropsychologia; 2008 Jan; 46(1):292-300. PubMed ID: 17765272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apomorphine-induced growth hormone response is attenuated by ethanol but not dextromethorphan.
    Budde H; Zimmermann US; Steffin B; Rommelspacher H; Schmidt LG; Smolka MN
    Alcohol Clin Exp Res; 2007 Jan; 31(1):100-3. PubMed ID: 17207107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of dopaminergic modulation of cognitive flexibility.
    Smyth SF; Beversdorf DQ
    Cogn Behav Neurol; 2007 Dec; 20(4):225-9. PubMed ID: 18091071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blunted growth hormone response is associated with early relapse in alcohol-dependent patients.
    Heinz A; Dettling M; Kuhn S; Dufeu P; Gräf KJ; Kürten I; Rommelspacher H; Schmidt IG
    Alcohol Clin Exp Res; 1995 Feb; 19(1):62-5. PubMed ID: 7771665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motor functioning and alcohol dependence.
    De Wilde B; Dom G; Hulstijn W; Sabbe B
    Alcohol Clin Exp Res; 2007 Nov; 31(11):1820-5. PubMed ID: 17877782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced dopaminergic function in alcoholics is related to severe dependence.
    Schmidt LG; Dettling M; Graef KJ; Heinz A; Kuhn S; Podschus J; Rommelspacher H
    Biol Psychiatry; 1996 Feb; 39(3):193-8. PubMed ID: 8837980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of dopamine D1 receptors in the avian fronto-striatal system adjusts daily cognitive fluctuations.
    Herold C; Diekamp B; Güntürkün O
    Behav Brain Res; 2008 Dec; 194(2):223-9. PubMed ID: 18692527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
    Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
    J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive functioning during methadone and buprenorphine treatment: results of a randomized clinical trial.
    Soyka M; Lieb M; Kagerer S; Zingg C; Koller G; Lehnert P; Limmer C; Kuefner H; Hennig-Fast K
    J Clin Psychopharmacol; 2008 Dec; 28(6):699-703. PubMed ID: 19011441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dopamine agonist apomorphine enhances conditioned pain modulation in healthy humans.
    Treister R; Pud D; Eisenberg E
    Neurosci Lett; 2013 Aug; 548():115-9. PubMed ID: 23727387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The apomorphine test: a biological marker for heroin dependence disorder?
    Guardia J; Casas M; Prat G; Trujols J; Segura L; Sánchez-Turet M
    Addict Biol; 2002 Oct; 7(4):421-6. PubMed ID: 14578019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.